cookies to track usage and preferences."
data-cookieaccepttext="I UNDERSTAND"
data-cookiedeclinetext="Disable Cookies"
data-cookiepolicytext="Privacy Policy">
The ‘tripledemic’ unfolding this winter is one of several odd trends among respiratory virus infections these last years. Viruses, it turns out, can block one another and take turns to dominate.
Antibiotics abound, but virus-fighting drugs are harder to come by, and Covid-19 amply shows how much we need them. Fortunately, scientists are getting better at making and finding them.
OPINION: Many Americans say they won’t take a vaccine. I am not one of <br xmlns="http://pub2web.metastore.ingenta.com/ns/"/>them — and I have the shots to prove it.
Some linger in the body for a lifetime. The one causing Covid-19 probably isn’t one of them, but it and others can create mischief long after the immune system appears to have banished them.
Out-of-control clotting can endanger some patients even after the virus has gone. Clinicians and researchers are trying to understand why it happens and how best to manage the problem.
While studies in mice and people can be slow, researchers are making fast progress testing medications in miniature airways and guts made of human cells
Antibodies should indicate if someone has had an infection in the past. But the promise of “immunity testing” is plagued by uncertainty about how the immune system responds to the coronavirus, as well as concerns about the tests’ accuracy.
An immune reaction gone wild seems to be linked with the most severe cases of pandemic Covid-19. Here’s what happens.
Close X
Science literacy is more important than ever. Help us combat misinformation.
Knowable Magazine’s award-winning science journalism is freely available for anyone, anywhere in the world. Our work provides a vital service in increasing the public’s understanding of science. But to keep everything free to read, we need your help. Donate today and help us inspire and inform readers everywhere.
